{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:24:44Z","timestamp":1790281484800,"version":"4.1.0"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,30]],"date-time":"2018-01-30T00:00:00Z","timestamp":1517270400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100013017","name":"VU University Medical Center","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013017","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Tissue Res"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s00441-017-2771-0","type":"journal-article","created":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T23:34:55Z","timestamp":1517268895000},"page":"327-336","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["The neurobiology of impulse control disorders in Parkinson\u2019s disease: from neurotransmitters to neural networks"],"prefix":"10.1007","volume":"373","author":[{"given":"Chris","family":"Vriend","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,30]]},"reference":[{"key":"2771_CR1","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1016\/j.neuroimage.2011.11.073","volume":"59","author":"E Aarts","year":"2012","unstructured":"Aarts E, Helmich RC, Janssen MJ, Oyen WJ, Bloem BR, Cools R (2012) Aberrant reward processing in Parkinson\u2019s disease is associated with dopamine cell loss. NeuroImage 59:3339\u20133346","journal-title":"NeuroImage"},{"key":"2771_CR2","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.nurt.2007.05.011","volume":"4","author":"AL Alexander","year":"2007","unstructured":"Alexander AL, Lee JE, Lazar M, Field AS (2007) Diffusion tensor imaging of the brain. Neurother: J Am Soc Exp Neurother Ther 4:316\u2013329","journal-title":"Neurother: J Am Soc Exp Neurother Ther"},{"key":"2771_CR3","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1136\/jnnp-2016-315277","volume":"88","author":"A Antonini","year":"2017","unstructured":"Antonini A, Barone P, Bonuccelli U, Annoni K, Asgharnejad M, Stanzione P (2017) ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 88:317\u2013324","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2771_CR4","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00213-011-2576-x","volume":"219","author":"PJ Baarendse","year":"2012","unstructured":"Baarendse PJ, Vanderschuren LJ (2012) Dissociable effects of monoamine reuptake inhibitors on distinct forms of impulsive behavior in rats. Psychopharmacology 219:313\u2013326","journal-title":"Psychopharmacology"},{"key":"2771_CR5","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s00213-012-2857-z","volume":"225","author":"PJ Baarendse","year":"2013","unstructured":"Baarendse PJ, Winstanley CA, Vanderschuren LJ (2013) Simultaneous blockade of dopamine and noradrenaline reuptake promotes disadvantageous decision making in a rat gambling task. Psychopharmacology 225:719\u2013731","journal-title":"Psychopharmacology"},{"key":"2771_CR6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.pneurobio.2013.06.005","volume":"108","author":"A Bari","year":"2013","unstructured":"Bari A, Robbins TW (2013) Inhibition and impulsivity: behavioral and neural basis of response control. Prog Neurobiol 108:44\u201379","journal-title":"Prog Neurobiol"},{"key":"2771_CR7","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00213-009-1537-0","volume":"205","author":"A Bari","year":"2009","unstructured":"Bari A, Eagle DM, Mar AC, Robinson ES, Robbins TW (2009) Dissociable effects of noradrenaline, dopamine, and serotonin uptake blockade on stop task performance in rats. Psychopharmacology 205:273\u2013283","journal-title":"Psychopharmacology"},{"key":"2771_CR8","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/mds.25291","volume":"28","author":"J Bastiaens","year":"2013","unstructured":"Bastiaens J, Dorfman BJ, Christos PJ, Nirenberg MJ (2013) Prospective cohort study of impulse control disorders in Parkinson\u2019s disease. Move Disord 28:327\u2013333","journal-title":"Move Disord"},{"key":"2771_CR9","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1212\/WNL.0b013e3181c2937c","volume":"73","author":"EE Benarroch","year":"2009","unstructured":"Benarroch EE (2009) The locus ceruleus norepinephrine system: functional organization and potential clinical significance. Neurology 73:1699\u20131704","journal-title":"Neurology"},{"key":"2771_CR10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jns.2011.08.001","volume":"310","author":"R Biundo","year":"2011","unstructured":"Biundo R, Formento-Dojot P, Facchini S, Vallelunga A, Ghezzo L, Foscolo L, Meneghello F, Antonini A (2011) Brain volume changes in Parkinson\u2019s disease and their relationship with cognitive and behavioural abnormalities. J Neurol Sci 310:64\u201369","journal-title":"J Neurol Sci"},{"key":"2771_CR11","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/mds.26154","volume":"30","author":"R Biundo","year":"2015","unstructured":"Biundo R, Weis L, Facchini S, Formento-Dojot P, Vallelunga A, Pilleri M, Weintraub D, Antonini A (2015) Patterns of cortical thickness associated with impulse control disorders in Parkinson\u2019s disease. Move Disord 30:688\u2013695","journal-title":"Move Disord"},{"key":"2771_CR12","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1038\/sj.jcbfm.9600276","volume":"26","author":"NI Bohnen","year":"2006","unstructured":"Bohnen NI, Albin RL, Koeppe RA, Wernette KA, Kilbourn MR, Minoshima S, Frey KA (2006) Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease. J Cereb Blood Flow Metab 26:1198\u20131212","journal-title":"J Cereb Blood Flow Metab"},{"key":"2771_CR13","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1111\/add.12066","volume":"108","author":"I Boileau","year":"2013","unstructured":"Boileau I, Payer D, Chugani B, Lobo D, Behzadi A, Rusjan PM, Houle S, Wilson AA, Warsh J, Kish SJ, Zack M (2013) The D2\/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride. Addiction 108:953\u2013963","journal-title":"Addiction"},{"key":"2771_CR14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/npp.2010.151","volume":"36","author":"Y-L Boureau","year":"2010","unstructured":"Boureau Y-L, Dayan P (2010) Opponency revisited: competition and cooperation between dopamine and serotonin. Neuropsychopharmacology 36:74\u201397","journal-title":"Neuropsychopharmacology"},{"key":"2771_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211","journal-title":"Neurobiol Aging"},{"key":"2771_CR16","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1212\/WNL.0000000000001619","volume":"84","author":"N Carriere","year":"2015","unstructured":"Carriere N, Lopes R, Defebvre L, Delmaire C, Dujardin K (2015) Impaired corticostriatal connectivity in impulse control disorders in Parkinson disease. Neurology 84:2116\u20132123","journal-title":"Neurology"},{"key":"2771_CR17","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.parkreldis.2014.09.001","volume":"20","author":"A Cerasa","year":"2014","unstructured":"Cerasa A, Salsone M, Nigro S, Chiriaco C, Donzuso G, Bosco D, Vasta R, Quattrone A (2014) Cortical volume and folding abnormalities in Parkinson\u2019s disease patients with pathological gambling. Parkinsonism Relat Disord 20:1209\u20131214","journal-title":"Parkinsonism Relat Disord"},{"key":"2771_CR18","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/j.1468-1331.2012.03878.x","volume":"20","author":"R Ceravolo","year":"2013","unstructured":"Ceravolo R, Frosini D, Poletti M, Kiferle L, Pagni C, Mazzucchi S, Volterrani D, Bonuccelli U (2013) Mild affective symptoms in de novo Parkinson\u2019s disease patients: relationship with dopaminergic dysfunction. Eur J Neurol 20:480\u2013485","journal-title":"Eur J Neurol"},{"key":"2771_CR19","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1126\/science.1121218","volume":"311","author":"SR Chamberlain","year":"2006","unstructured":"Chamberlain SR, Muller U, Blackwell AD, Clark L, Robbins TW, Sahakian BJ (2006) Neurochemical modulation of response inhibition and probabilistic learning in humans. Science 311:861\u2013863","journal-title":"Science"},{"key":"2771_CR20","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.biopsych.2007.03.003","volume":"62","author":"SR Chamberlain","year":"2007","unstructured":"Chamberlain SR, Del Campo N, Dowson J, Muller U, Clark L, Robbins TW, Sahakian BJ (2007) Atomoxetine improved response inhibition in adults with attention deficit\/hyperactivity disorder. Biol Psychiatry 62:977\u2013984","journal-title":"Biol Psychiatry"},{"key":"2771_CR21","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/ana.21995","volume":"67","author":"HC Cheng","year":"2010","unstructured":"Cheng HC, Ulane CM, Burke RE (2010) Clinical progression in Parkinson disease and the neurobiology of axons. Ann Neurol 67:715\u2013725","journal-title":"Ann Neurol"},{"key":"2771_CR22","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.nbd.2010.03.013","volume":"39","author":"R Cilia","year":"2010","unstructured":"Cilia R, Ko JH, Cho SS, van Eimeren T, Marotta G, Pellecchia G, Pezzoli G, Antonini A, Strafella AP (2010) Reduced dopamine transporter density in the ventral striatum of patients with Parkinson\u2019s disease and pathological gambling. Neurobiol Dis 39:98\u2013104","journal-title":"Neurobiol Dis"},{"key":"2771_CR23","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1037\/a0023795","volume":"125","author":"DO Claassen","year":"2011","unstructured":"Claassen DO, van den Wildenberg WP, Ridderinkhof KR, Jessup CK, Harrison MB, Wooten GF, Wylie SA (2011) The risky business of dopamine agonists in Parkinson disease and impulse control disorders. Behav Neurosci 125:492\u2013500","journal-title":"Behav Neurosci"},{"key":"2771_CR24","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00213-016-4447-y","volume":"234","author":"PJ Cocker","year":"2017","unstructured":"Cocker PJ, Tremblay M, Kaur S, Winstanley CA (2017) Chronic administration of the dopamine D2\/3 agonist ropinirole invigorates performance of a rodent slot machine task, potentially indicative of less distractible or compulsive-like gambling behaviour. Psychopharmacology 234:137\u2013153","journal-title":"Psychopharmacology"},{"key":"2771_CR25","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1001\/jama.2014.3654","volume":"311","author":"BS Connolly","year":"2014","unstructured":"Connolly BS, Lang AE (2014) Pharmacological treatment of Parkinson disease: a review. JAMA 311:1670\u20131683","journal-title":"JAMA"},{"key":"2771_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neubiorev.2005.03.024","volume":"30","author":"R Cools","year":"2006","unstructured":"Cools R (2006) Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson\u2019s disease. Neurosci Biobehav Rev 30:1\u201323","journal-title":"Neurosci Biobehav Rev"},{"key":"2771_CR27","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1016\/j.biopsych.2011.03.028","volume":"69","author":"R Cools","year":"2011","unstructured":"Cools R, D\u2019Esposito M (2011) Inverted-U-shaped dopamine actions on human working memory and cognitive control. Biol Psychiatry 69:e113\u2013e125","journal-title":"Biol Psychiatry"},{"key":"2771_CR28","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/j.neuropsychologia.2006.03.030","volume":"44","author":"R Cools","year":"2006","unstructured":"Cools R, Altamirano L, D\u2019Esposito M (2006) Reversal learning in Parkinson\u2019s disease depends on medication status and outcome valence. Neuropsychologia 44:1663\u20131673","journal-title":"Neuropsychologia"},{"key":"2771_CR29","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11910-016-0647-4","volume":"16","author":"JW Cooney","year":"2016","unstructured":"Cooney JW, Stacy M (2016) Neuropsychiatric issues in Parkinson\u2019s disease. Curr Neurol Neurosci Rep 16:49","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2771_CR30","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1126\/science.1137073","volume":"315","author":"JW Dalley","year":"2007","unstructured":"Dalley JW, Fryer TD, Brichard L, Robinson ES, Theobald DE, Laane K, Pena Y, Murphy ER, Shah Y, Probst K, Abakumova I, Aigbirhio FI, Richards HK, Hong Y, Baron JC, Everitt BJ, Robbins TW (2007) Nucleus accumbens D2\/3 receptors predict trait impulsivity and cocaine reinforcement. Science 315:1267\u20131270","journal-title":"Science"},{"issue":"Pt 8","key":"2771_CR31","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/brain\/122.8.1437","volume":"122","author":"P Damier","year":"1999","unstructured":"Damier P, Hirsch EC, Agid Y, Graybiel AM (1999) The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson\u2019s disease. Brain 122(Pt 8):1437\u20131448","journal-title":"Brain"},{"key":"2771_CR32","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1038\/sj.npp.1300728","volume":"30","author":"CM Del-Ben","year":"2005","unstructured":"Del-Ben CM, Deakin JF, McKie S, Delvai NA, Williams SR, Elliott R, Dolan M, Anderson IM (2005) The effect of citalopram pretreatment on neuronal responses to neuropsychological tasks in normal volunteers: an FMRI study. Neuropsychopharmacology 30:1724\u20131734","journal-title":"Neuropsychopharmacology"},{"key":"2771_CR33","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.parkreldis.2010.12.014","volume":"17","author":"A Djamshidian","year":"2011","unstructured":"Djamshidian A, O\u2019Sullivan SS, Lees A, Averbeck BB (2011) Stroop test performance in impulsive and non impulsive patients with Parkinson\u2019s disease. Parkinsonism Relat Disord 17:212\u2013214","journal-title":"Parkinsonism Relat Disord"},{"key":"2771_CR34","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/npp.2008.202","volume":"34","author":"DM Eagle","year":"2009","unstructured":"Eagle DM, Lehmann O, Theobald DE, Pena Y, Zakaria R, Ghosh R, Dalley JW, Robbins TW (2009) Serotonin depletion impairs waiting but not stop-signal reaction time in rats: implications for theories of the role of 5-HT in behavioral inhibition. Neuropsychopharmacology 34:1311\u20131321","journal-title":"Neuropsychopharmacology"},{"issue":"Pt 5","key":"2771_CR35","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","volume":"114","author":"JM Fearnley","year":"1991","unstructured":"Fearnley JM, Lees AJ (1991) Ageing and Parkinson\u2019s disease: substantia nigra regional selectivity. Brain 114(Pt 5):2283\u20132301","journal-title":"Brain"},{"key":"2771_CR36","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1126\/science.1102941","volume":"306","author":"MJ Frank","year":"2004","unstructured":"Frank MJ, Seeberger LC, O\u2019Reilly RC (2004) By carrot or by stick: cognitive reinforcement learning in parkinsonism. Science 306:1940\u20131943","journal-title":"Science"},{"key":"2771_CR37","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.parkreldis.2008.04.038","volume":"15","author":"PG Frisina","year":"2009","unstructured":"Frisina PG, Haroutunian V, Libow LS (2009) The neuropathological basis for depression in Parkinson\u2019s disease. Parkinsonism Relat Disord 15:144\u2013148","journal-title":"Parkinsonism Relat Disord"},{"key":"2771_CR38","doi-asserted-by":"crossref","unstructured":"Frosini D, Pesaresi I, Cosottini M, Belmonte G, Rossi C, Dell\u2019Osso L, Murri L, Bonuccelli U, Ceravolo R (2010) Parkinson\u2019s disease and pathological gambling: results from a functional MRI study. Move Disord 25:2449\u20132453","DOI":"10.1002\/mds.23369"},{"key":"2771_CR39","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-neuro-061010-113641","volume":"34","author":"CR Gerfen","year":"2011","unstructured":"Gerfen CR, Surmeier DJ (2011) Modulation of striatal projection systems by dopamine. Annu Rev Neurosci 34:441\u2013466","journal-title":"Annu Rev Neurosci"},{"key":"2771_CR40","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s00702-003-0027-5","volume":"110","author":"M Gerlach","year":"2003","unstructured":"Gerlach M, Double K, Arzberger T, Leblhuber F, Tatschner T, Riederer P (2003) Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human striatum. J Neural Transm 110:1119\u20131127","journal-title":"J Neural Transm"},{"key":"2771_CR41","doi-asserted-by":"publisher","first-page":"783","DOI":"10.4088\/JCP.v69n0511","volume":"69","author":"JE Grant","year":"2008","unstructured":"Grant JE, Kim SW, Hartman BK (2008) A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges. J Clin Psychiatry 69:783\u2013789","journal-title":"J Clin Psychiatry"},{"key":"2771_CR42","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/npp.2009.129","volume":"35","author":"SN Haber","year":"2010","unstructured":"Haber SN, Knutson B (2010) The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology 35:4\u201326","journal-title":"Neuropsychopharmacology"},{"key":"2771_CR43","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0166-4328(98)00117-X","volume":"100","author":"AA Harrison","year":"1999","unstructured":"Harrison AA, Everitt BJ, Robbins TW (1999) Central serotonin depletion impairs both the acquisition and performance of a symmetrically reinforced go\/no-go conditional visual discrimination. Behav Brain Res 100:99\u2013112","journal-title":"Behav Brain Res"},{"key":"2771_CR44","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1111\/j.1460-9568.2007.05839.x","volume":"26","author":"JR Homberg","year":"2007","unstructured":"Homberg JR, Pattij T, Janssen MC, Ronken E, De Boer SF, Schoffelmeer AN, Cuppen E (2007) Serotonin transporter deficiency in rats improves inhibitory control but not behavioural flexibility. Eur J Neurosci 26:2066\u20132073","journal-title":"Eur J Neurosci"},{"key":"2771_CR45","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1001\/jamaneurol.2014.290","volume":"71","author":"IT Hsiao","year":"2014","unstructured":"Hsiao IT, Weng YH, Hsieh CJ, Lin WY, Wey SP, Kung MP, Yen TC, Lu CS, Lin KJ (2014a) Correlation of Parkinson disease severity and 18F-DTBZ positron emission tomography. JAMA Neurol 71:758\u2013766","journal-title":"JAMA Neurol"},{"key":"2771_CR46","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.nucmedbio.2013.12.017","volume":"41","author":"IT Hsiao","year":"2014","unstructured":"Hsiao IT, Weng YH, Lin WY, Hsieh CJ, Wey SP, Yen TC, Kung MP, Lu CS, Lin KJ (2014b) Comparison of 99mTc-TRODAT-1 SPECT and 18 F-AV-133 PET imaging in healthy controls and Parkinson\u2019s disease patients. Nucl Med Biol 41:322\u2013329","journal-title":"Nucl Med Biol"},{"key":"2771_CR47","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00213-010-2006-5","volume":"213","author":"PS Johnson","year":"2011","unstructured":"Johnson PS, Madden GJ, Brewer AT, Pinkston JW, Fowler SC (2011) Effects of acute pramipexole on preference for gambling-like schedules of reinforcement in rats. Psychopharmacology 213:11\u201318","journal-title":"Psychopharmacology"},{"key":"2771_CR48","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.parkreldis.2012.06.005","volume":"18","author":"J Joutsa","year":"2012","unstructured":"Joutsa J, Martikainen K, Vahlberg T, Kaasinen V (2012a) Effects of dopamine agonist dose and gender on the prognosis of impulse control disorders in Parkinson\u2019s disease. Parkinsonism Relat Disord 18:1079\u20131083","journal-title":"Parkinsonism Relat Disord"},{"key":"2771_CR49","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.parkreldis.2011.09.007","volume":"18","author":"J Joutsa","year":"2012","unstructured":"Joutsa J, Martikainen K, Vahlberg T, Voon V, Kaasinen V (2012b) Impulse control disorders and depression in Finnish patients with Parkinson\u2019s disease. Parkinsonism Relat Disord 18:155\u2013160","journal-title":"Parkinsonism Relat Disord"},{"key":"2771_CR50","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1093\/brain\/awu117","volume":"137","author":"AA Kehagia","year":"2014","unstructured":"Kehagia AA, Housden CR, Regenthal R, Barker RA, Muller U, Rowe J, Sahakian BJ, Robbins TW (2014) Targeting impulsivity in Parkinson\u2019s disease using atomoxetine. Brain 137:1986\u20131997","journal-title":"Brain"},{"key":"2771_CR51","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1056\/NEJM198804073181402","volume":"318","author":"SJ Kish","year":"1988","unstructured":"Kish SJ, Shannak K, Hornykiewicz O (1988) Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson\u2019s disease. Pathophysiologic and clinical implications. N Engl J Med 318:876\u2013880","journal-title":"N Engl J Med"},{"key":"2771_CR52","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.parkreldis.2016.06.005","volume":"30","author":"S Krishnamoorthy","year":"2016","unstructured":"Krishnamoorthy S, Rajan R, Banerjee M, Kumar H, Sarma G, Krishnan S, Sarma S, Kishore A (2016) Dopamine D3 receptor Ser9Gly variant is associated with impulse control disorders in Parkinson\u2019s disease patients. Parkinsonism Relat Disord 30:13\u201317","journal-title":"Parkinsonism Relat Disord"},{"key":"2771_CR53","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1002\/mds.22678","volume":"24","author":"JY Lee","year":"2009","unstructured":"Lee JY, Lee EK, Park SS, Lim JY, Kim HJ, Kim JS, Jeon BS (2009) Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson\u2019s disease. Move Disord 24:1803\u20131810","journal-title":"Move Disord"},{"key":"2771_CR54","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1136\/jnnp-2013-305549","volume":"85","author":"JY Lee","year":"2014","unstructured":"Lee JY, Seo SH, Kim YK, Yoo HB, Kim YE, Song IC, Lee JS, Jeon BS (2014) Extrastriatal dopaminergic changes in Parkinson\u2019s disease patients with impulse control disorders. J Neurol Neurosurg Psychiatry 85:23\u201330","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2771_CR55","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00702-016-1648-9","volume":"124","author":"B Leplow","year":"2017","unstructured":"Leplow B, Sepke M, Schonfeld R, Pohl J, Oelsner H, Latzko L, Ebersbach G (2017) Impaired learning of punishments in Parkinson\u2019s disease with and without impulse control disorder. J Neural Transm (Vienna) 124:217\u2013225","journal-title":"J Neural Transm (Vienna)"},{"key":"2771_CR56","first-page":"167","volume":"66","author":"SY Lim","year":"2009","unstructured":"Lim SY, Fox SH, Lang AE (2009) Overview of the extranigral aspects of Parkinson disease. Arch Neurol 66:167\u2013172","journal-title":"Arch Neurol"},{"key":"2771_CR57","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/npp.2012.264","volume":"38","author":"J Macoveanu","year":"2012","unstructured":"Macoveanu J, Hornboll B, Elliott R, Erritzoe D, Paulson OB, Siebner H, Knudsen GM, Rowe JB (2012) Serotonin 2A receptors, citalopram and tryptophan-depletion: a multimodal imaging study of their interactions during response inhibition. Neuropsychopharmacology 38:996\u20131005","journal-title":"Neuropsychopharmacology"},{"key":"2771_CR58","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jns.2016.12.058","volume":"374","author":"EM Maloney","year":"2017","unstructured":"Maloney EM, Djamshidian A, O\u2019Sullivan SS (2017) Phenomenology and epidemiology of impulsive-compulsive behaviours in Parkinson\u2019s disease, atypical parkinsonian disorders and non-parkinsonian populations. J Neurol Sci 374:47\u201352","journal-title":"J Neurol Sci"},{"key":"2771_CR59","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1097\/01.ALC.0000099264.36220.48","volume":"27","author":"LD Middaugh","year":"2003","unstructured":"Middaugh LD, Szumlinski KK, Van Patten Y, Marlowe AL, Kalivas PW (2003) Chronic ethanol consumption by C57BL\/6 mice promotes tolerance to its interoceptive cues and increases extracellular dopamine, an effect blocked by naltrexone. Alcohol Clin Exp Res 27:1892\u20131900","journal-title":"Alcohol Clin Exp Res"},{"key":"2771_CR60","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/brain\/awl326","volume":"130","author":"O Monchi","year":"2007","unstructured":"Monchi O, Petrides M, Mejia-Constain B, Strafella AP (2007) Cortical activity in Parkinson\u2019s disease during executive processing depends on striatal involvement. Brain J Neurol 130:233\u2013244","journal-title":"Brain J Neurol"},{"key":"2771_CR61","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1093\/brain\/aww188","volume":"139","author":"K Muhammed","year":"2016","unstructured":"Muhammed K, Manohar S, Ben Yehuda M, Chong TT, Tofaris G, Lennox G, Bogdanovic M, Hu M, Husain M (2016) Reward sensitivity deficits modulated by dopamine are associated with apathy in Parkinson\u2019s disease. Brain J Neurol 139:2706\u20132721","journal-title":"Brain J Neurol"},{"key":"2771_CR62","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/nn1737","volume":"9","author":"MA Nader","year":"2006","unstructured":"Nader MA, Morgan D, Gage HD, Nader SH, Calhoun TL, Buchheimer N, Ehrenkaufer R, Mach RH (2006) PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys. Nat Neurosci 9:1050\u20131056","journal-title":"Nat Neurosci"},{"key":"2771_CR63","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.biopsych.2010.11.014","volume":"69","author":"LS Nandam","year":"2011","unstructured":"Nandam LS, Hester R, Wagner J, Cummins TD, Garner K, Dean AJ, Kim BN, Nathan PJ, Mattingley JB, Bellgrove MA (2011) Methylphenidate but not atomoxetine or citalopram modulates inhibitory control and response time variability. Biol Psychiatry 69:902\u2013904","journal-title":"Biol Psychiatry"},{"key":"2771_CR64","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00221-011-2793-x","volume":"213","author":"I Obeso","year":"2011","unstructured":"Obeso I, Wilkinson L, Jahanshahi M (2011) Levodopa medication does not influence motor inhibition or conflict resolution in a conditional stop-signal task in Parkinson\u2019s disease. Exp Brain Res 213:435\u2013445","journal-title":"Exp Brain Res"},{"key":"2771_CR65","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1136\/jnnp-2012-304558","volume":"85","author":"C O\u2019Callaghan","year":"2014","unstructured":"O\u2019Callaghan C, Bertoux M, Hornberger M (2014) Beyond and below the cortex: the contribution of striatal dysfunction to cognition and behaviour in neurodegeneration. J Neurol Neurosurg Psychiatry 85:371\u2013378","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2771_CR66","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2967\/jnumed.109.070094","volume":"51","author":"N Okamura","year":"2010","unstructured":"Okamura N, Villemagne VL, Drago J, Pejoska S, Dhamija RK, Mulligan RS, Ellis JR, Ackermann U, O\u2019Keefe G, Jones G, Kung HF, Pontecorvo MJ, Skovronsky D, Rowe CC (2010) In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with (18)F-AV-133. J Nucl Med 51:223\u2013228","journal-title":"J Nucl Med"},{"key":"2771_CR67","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/brain\/awr003","volume":"134","author":"SS O\u2019Sullivan","year":"2011","unstructured":"O\u2019Sullivan SS, Wu K, Politis M, Lawrence AD, Evans AH, Bose SK, Djamshidian A, Lees AJ, Piccini P (2011) Cue-induced striatal dopamine release in Parkinson\u2019s disease-associated impulsive-compulsive behaviours. Brain J Neurol 134:969\u2013978","journal-title":"Brain J Neurol"},{"key":"2771_CR68","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1212\/WNL.0000000000000729","volume":"83","author":"K Papay","year":"2014","unstructured":"Papay K, Xie SX, Stern M, Hurtig H, Siderowf A, Duda JE, Minger J, Weintraub D (2014) Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study. Neurology 83:826\u2013833","journal-title":"Neurology"},{"key":"2771_CR69","doi-asserted-by":"crossref","unstructured":"Pattij T, Schoffelmeer AN (2014) Serotonin and inhibitory response control: Focusing on the role of 5-HT receptors. Eur J Pharmacol 753:140\u2013145","DOI":"10.1016\/j.ejphar.2014.05.064"},{"key":"2771_CR70","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/mds.26135","volume":"30","author":"DE Payer","year":"2015","unstructured":"Payer DE, Guttman M, Kish SJ, Tong J, Strafella A, Zack M, Adams JR, Rusjan P, Houle S, Furukawa Y, Wilson AA, Boileau I (2015) [(1)(1)C]-(+)-PHNO PET imaging of dopamine D(2\/3) receptors in Parkinson\u2019s disease with impulse control disorders. Move Disord 30:160\u2013166","journal-title":"Move Disord"},{"key":"2771_CR71","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1007\/s00415-015-7892-3","volume":"262","author":"C Pellicano","year":"2015","unstructured":"Pellicano C, Niccolini F, Wu K, O\u2019Sullivan SS, Lawrence AD, Lees AJ, Piccini P, Politis M (2015) Morphometric changes in the reward system of Parkinson\u2019s disease patients with impulse control disorders. J Neurol 262:2653\u20132661","journal-title":"J Neurol"},{"key":"2771_CR72","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S0006-3223(03)00171-9","volume":"54","author":"ML Phillips","year":"2003","unstructured":"Phillips ML, Drevets WC, Rauch SL, Lane R (2003) Neurobiology of emotion perception II: implications for major psychiatric disorders. Biol Psychiatry 54:515\u2013528","journal-title":"Biol Psychiatry"},{"issue":"829","key":"2771_CR73","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/mp.2008.65","volume":"13","author":"ML Phillips","year":"2008","unstructured":"Phillips ML, Ladouceur CD, Drevets WC (2008) A neural model of voluntary and automatic emotion regulation: implications for understanding the pathophysiology and neurodevelopment of bipolar disorder. Mol Psychiatry 13(829):833\u2013857","journal-title":"Mol Psychiatry"},{"key":"2771_CR74","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1517\/14656566.2016.1145660","volume":"17","author":"M Piquet-Pessoa","year":"2016","unstructured":"Piquet-Pessoa M, Fontenelle LF (2016) Opioid antagonists in broadly defined behavioral addictions: a narrative review. Expert Opin Pharmacother 17:835\u2013844","journal-title":"Expert Opin Pharmacother"},{"key":"2771_CR75","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1212\/WNL.0b013e3181feb2ab","volume":"75","author":"M Politis","year":"2010","unstructured":"Politis M, Wu K, Loane C, Turkheimer FE, Molloy S, Brooks DJ, Piccini P (2010) Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures. Neurology 75:1920\u20131927","journal-title":"Neurology"},{"key":"2771_CR76","doi-asserted-by":"crossref","unstructured":"Politis M, Loane C, Wu K, O\u2019Sullivan SS, Woodhead Z, Kiferle L, Lawrence AD, Lees AJ, Piccini P (2013) Neural response to visual sexual cues in dopamine treatment-linked hypersexuality in Parkinson\u2019s disease. Brain 136:400\u2013411","DOI":"10.1093\/brain\/aws326"},{"key":"2771_CR77","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1152\/jn.00516.2010","volume":"105","author":"GA Prieto","year":"2011","unstructured":"Prieto GA, Perez-Burgos A, Palomero-Rivero M, Galarraga E, Drucker-Colin R, Bargas J (2011) Upregulation of D2-class signaling in dopamine-denervated striatum is in part mediated by D3 receptors acting on ca V 2.1 channels via PIP2 depletion. J Neurophysiol 105:2260\u20132274","journal-title":"J Neurophysiol"},{"key":"2771_CR78","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/j.neuroimage.2012.06.012","volume":"62","author":"CL Rae","year":"2012","unstructured":"Rae CL, Correia MM, Altena E, Hughes LE, Barker RA, Rowe JB (2012) White matter pathology in Parkinson\u2019s disease: the effect of imaging protocol differences and relevance to executive function. NeuroImage 62:1675\u20131684","journal-title":"NeuroImage"},{"key":"2771_CR79","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1586\/14737175.2016.1158103","volume":"16","author":"A Ramirez-Zamora","year":"2016","unstructured":"Ramirez-Zamora A, Gee L, Boyd J, Biller J (2016) Treatment of impulse control disorders in Parkinson\u2019s disease: practical considerations and future directions. Expert Rev Neurother 16:389\u2013399","journal-title":"Expert Rev Neurother"},{"issue":"11","key":"2771_CR80","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1002\/mds.23147","volume":"25","author":"H Rao","year":"2010","unstructured":"Rao H, Mamikonyan E, Detre JA, Siderowf AD, Stern MB, Potenza MN, Weintraub D (2010) Decreased ventral striatal activity with impulse control disorders in Parkinson\u2019s disease. Mov Disord 25(11):1660\u20131669","journal-title":"Mov Disord"},{"key":"2771_CR81","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.nbd.2012.06.021","volume":"48","author":"NJ Ray","year":"2012","unstructured":"Ray NJ, Miyasaki JM, Zurowski M, Ko JH, Cho SS, Pellecchia G, Antonelli F, Houle S, Lang AE, Strafella AP (2012) Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson\u2019s patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study. Neurobiol Dis 48:519\u2013525","journal-title":"Neurobiol Dis"},{"key":"2771_CR82","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1093\/brain\/awh445","volume":"128","author":"P Remy","year":"2005","unstructured":"Remy P, Doder M, Lees A, Turjanski N, Brooks D (2005) Depression in Parkinson\u2019s disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain J Neurol 128:1314\u20131322","journal-title":"Brain J Neurol"},{"key":"2771_CR83","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/sj.npp.1301487","volume":"33","author":"ES Robinson","year":"2008","unstructured":"Robinson ES, Eagle DM, Mar AC, Bari A, Banerjee G, Jiang X, Dalley JW, Robbins TW (2008) Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat. Neuropsychopharmacology 33:1028\u20131037","journal-title":"Neuropsychopharmacology"},{"key":"2771_CR84","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/npp.2011.325","volume":"37","author":"SL Rokosik","year":"2012","unstructured":"Rokosik SL, Napier TC (2012) Pramipexole-induced increased probabilistic discounting: comparison between a rodent model of Parkinson\u2019s disease and controls. Neuropsychopharmacology 37:1397\u20131408","journal-title":"Neuropsychopharmacology"},{"key":"2771_CR85","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.bcp.2007.01.036","volume":"74","author":"KS Rommelfanger","year":"2007","unstructured":"Rommelfanger KS, Weinshenker D (2007) Norepinephrine: the redheaded stepchild of Parkinson\u2019s disease. Biochem Pharmacol 74:177\u2013190","journal-title":"Biochem Pharmacol"},{"key":"2771_CR86","doi-asserted-by":"crossref","unstructured":"Rosner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont M, Soyka M (2010) Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev CD001867","DOI":"10.1002\/14651858.CD001867.pub3"},{"key":"2771_CR87","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/mds.22472","volume":"24","author":"G Santangelo","year":"2009","unstructured":"Santangelo G, Vitale C, Trojano L, Verde F, Grossi D, Barone P (2009) Cognitive dysfunctions and pathological gambling in patients with Parkinson\u2019s disease. Move Disord 24:899\u2013905","journal-title":"Move Disord"},{"key":"2771_CR88","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1002\/mds.21505","volume":"22","author":"C Scherfler","year":"2007","unstructured":"Scherfler C, Schwarz J, Antonini A, Grosset D, Valldeoriola F, Marek K, Oertel W, Tolosa E, Lees AJ, Poewe W (2007) Role of DAT-SPECT in the diagnostic work up of parkinsonism. Move Disord 22:1229\u20131238","journal-title":"Move Disord"},{"issue":"Suppl 3","key":"2771_CR89","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1002\/mds.23884","volume":"26","author":"K Seppi","year":"2011","unstructured":"Seppi K, Weintraub D, Coelho M, Perez-Lloret S, Fox SH, Katzenschlager R, Hametner EM, Poewe W, Rascol O, Goetz CG, Sampaio C (2011) The Movement Disorder Society evidence-based medicine review update: treatments for the non-motor symptoms of Parkinson\u2019s disease. Move Disord 26(Suppl 3):S42\u2013S80","journal-title":"Move Disord"},{"key":"2771_CR90","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1136\/jnnp-2015-311827","volume":"87","author":"KM Smith","year":"2016","unstructured":"Smith KM, Xie SX, Weintraub D (2016) Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease. J Neurol Neurosurg Psychiatry 87:864\u2013870","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2771_CR91","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1093\/brain\/awp054","volume":"132","author":"TD Steeves","year":"2009","unstructured":"Steeves TD, Miyasaki J, Zurowski M, Lang AE, Pellecchia G, Van Eimeren T, Rusjan P, Houle S, Strafella AP (2009) Increased striatal dopamine release in parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain J Neurol 132:1376\u20131385","journal-title":"Brain J Neurol"},{"key":"2771_CR92","first-page":"119","volume":"24","author":"P Tanwani","year":"2015","unstructured":"Tanwani P, Fernie BA, Nikcevic AV, Spada MM (2015) A systematic review of treatments for impulse control disorders and related behaviours in Parkinson\u2019s disease. Psychiatry research 225:402-406Tessitore a, Santangelo G, de Micco R, Vitale C, Giordano a, Raimo S, Corbo D, Amboni M, Barone P, Tedeschi G (2016) cortical thickness changes in patients with Parkinson\u2019s disease and impulse control disorders. Parkinsonism Relat Disord 24:119\u2013125","journal-title":"Parkinsonism Relat Disord"},{"key":"2771_CR93","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.parkreldis.2015.10.013","volume":"24","author":"A Tessitore","year":"2016","unstructured":"Tessitore A, Santangelo G, De Micco R, Vitale C, Giordano A, Raimo S, Corbo D, Amboni M, Barone P, Tedeschi G (2016) Cortical thickness changes in patients with Parkinson\u2019s disease and impulse control disorders. Parkinsonism Relat Disord 24:119\u2013125","journal-title":"Parkinsonism Relat Disord"},{"key":"2771_CR94","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1093\/brain\/awq032","volume":"133","author":"S Thobois","year":"2010","unstructured":"Thobois S, Ardouin C, Lhommee E, Klinger H, Lagrange C, Xie J, Fraix V, Coelho Braga MC, Hassani R, Kistner A, Juphard A, Seigneuret E, Chabardes S, Mertens P, Polo G, Reilhac A, Costes N, LeBars D, Savasta M, Tremblay L, Quesada JL, Bosson JL, Benabid AL, Broussolle E, Pollak P, Krack P (2010) Non-motor dopamine withdrawal syndrome after surgery for Parkinson\u2019s disease: predictors and underlying mesolimbic denervation. Brain 133:1111\u20131127","journal-title":"Brain"},{"key":"2771_CR95","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1212\/01.wnl.0000252368.25106.b6","volume":"68","author":"M Tippmann-Peikert","year":"2007","unstructured":"Tippmann-Peikert M, Park JG, Boeve BF, Shepard JW, Silber MH (2007) Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists. Neurology 68:301\u2013303","journal-title":"Neurology"},{"key":"2771_CR96","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/ejn.13332","volume":"45","author":"M Tremblay","year":"2017","unstructured":"Tremblay M, Silveira MM, Kaur S, Hosking JG, Adams WK, Baunez C, Winstanley CA (2017) Chronic D2\/3 agonist ropinirole treatment increases preference for uncertainty in rats regardless of baseline choice patterns. Eur J Neurosci 45:159\u2013166","journal-title":"Eur J Neurosci"},{"key":"2771_CR97","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.parkreldis.2011.10.019","volume":"18","author":"A Vallelunga","year":"2012","unstructured":"Vallelunga A, Flaibani R, Formento-Dojot P, Biundo R, Facchini S, Antonini A (2012) Role of genetic polymorphisms of the dopaminergic system in Parkinson\u2019s disease patients with impulse control disorders. Parkinsonism Relat Disord 18:397\u2013399","journal-title":"Parkinsonism Relat Disord"},{"key":"2771_CR98","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.parkreldis.2016.05.014","volume":"28","author":"TD Balkom van","year":"2016","unstructured":"van Balkom TD, Vriend C, Berendse HW, Foncke EM, van der Werf YD, van den Heuvel OA, Klein M (2016) Profiling cognitive and neuropsychiatric heterogeneity in Parkinson\u2019s disease. Parkinsonism Relat Disord 28:130\u2013136","journal-title":"Parkinsonism Relat Disord"},{"key":"2771_CR99","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1038\/npp.2009.124","volume":"34","author":"T Eimeren van","year":"2009","unstructured":"van Eimeren T, Ballanger B, Pellecchia G, Miyasaki JM, Lang AE, Strafella AP (2009) Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson\u2019s disease? Neuropsychopharmacology 34:2758\u20132766","journal-title":"Neuropsychopharmacology"},{"key":"2771_CR100","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1162\/jocn_a_01099","volume":"29","author":"NC Wouwe Van","year":"2017","unstructured":"Van Wouwe NC, Claassen DO, Neimat JS, Kanoff KE, Wylie SA (2017) Dopamine selectively modulates the outcome of learning unnatural action-valence associations. J Cogn Neurosci 29:816\u2013826","journal-title":"J Cogn Neurosci"},{"key":"2771_CR101","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jns.2016.07.003","volume":"368","author":"L Vela","year":"2016","unstructured":"Vela L, Martinez Castrillo JC, Garcia Ruiz P, Gasca-Salas C, Macias Macias Y, Perez Fernandez E, Ybot I, Lopez Valdes E, Kurtis MM, Posada Rodriguez IJ, Mata M, Ruiz Huete C, Eimil M, Borrue C, Del Val J, Lopez-Manzanares L, Rojo Sebastian A, Marasescu R (2016) The high prevalence of impulse control behaviors in patients with early-onset Parkinson\u2019s disease: a cross-sectional multicenter study. J Neurol Sci 368:150\u2013154","journal-title":"J Neurol Sci"},{"key":"2771_CR102","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/mds.23567","volume":"26","author":"C Vitale","year":"2011","unstructured":"Vitale C, Santangelo G, Trojano L, Verde F, Rocco M, Grossi D, Barone P (2011) Comparative neuropsychological profile of pathological gambling, hypersexuality, and compulsive eating in Parkinson\u2019s disease. Move Disord 26:830\u2013836","journal-title":"Move Disord"},{"key":"2771_CR103","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/syn.10137","volume":"46","author":"ND Volkow","year":"2002","unstructured":"Volkow ND, Wang GJ, Fowler JS, Thanos PP, Logan J, Gatley SJ, Gifford A, Ding YS, Wong C, Pappas N (2002) Brain DA D2 receptors predict reinforcing effects of stimulants in humans: replication study. Synapse 46:79\u201382","journal-title":"Synapse"},{"key":"2771_CR104","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.neuroimage.2008.06.002","volume":"42","author":"ND Volkow","year":"2008","unstructured":"Volkow ND, Wang GJ, Telang F, Fowler JS, Thanos PK, Logan J, Alexoff D, Ding YS, Wong C, Ma Y, Pradhan K (2008) Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors. NeuroImage 42:1537\u20131543","journal-title":"NeuroImage"},{"key":"2771_CR105","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1093\/brain\/awr080","volume":"134","author":"V Voon","year":"2011","unstructured":"Voon V, Gao J, Brezing C, Symmonds M, Ekanayake V, Fernandez H, Dolan RJ, Hallett M (2011a) Dopamine agonists and risk: impulse control disorders in Parkinson\u2019s disease. Brain J Neurol 134:1438\u20131446","journal-title":"Brain J Neurol"},{"key":"2771_CR106","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/WCO.0b013e3283489687","volume":"24","author":"V Voon","year":"2011","unstructured":"Voon V, Mehta AR, Hallett M (2011b) Impulse control disorders in Parkinson\u2019s disease: recent advances. Curr Opin Neurol 24:324\u2013330","journal-title":"Curr Opin Neurol"},{"key":"2771_CR107","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1136\/jnnp-2013-305395","volume":"85","author":"V Voon","year":"2014","unstructured":"Voon V, Rizos A, Chakravartty R, Mulholland N, Robinson S, Howell NA, Harrison N, Vivian G, Ray Chaudhuri K (2014) Impulse control disorders in Parkinson\u2019s disease: decreased striatal dopamine transporter levels. J Neurol Neurosurg Psychiatry 85:148\u2013152","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2771_CR108","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S1474-4422(17)30004-2","volume":"16","author":"V Voon","year":"2017","unstructured":"Voon V, Napier TC, Frank MJ, Sgambato-Faure V, Grace AA, Rodriguez-Oroz M, Obeso J, Bezard E, Fernagut PO (2017) Impulse control disorders and levodopa-induced dyskinesias in Parkinson\u2019s disease: an update. Lancet Neurol 16:238\u2013250","journal-title":"Lancet Neurol"},{"key":"2771_CR109","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1002\/mds.25886","volume":"29","author":"C Vriend","year":"2014","unstructured":"Vriend C, Nordbeck AH, Booij J, van der Werf YD, Pattij T, Voorn P, Raijmakers P, Foncke EM, van de Giessen E, Berendse HW, van den Heuvel OA (2014a) Reduced dopamine transporter binding predates impulse control disorders in Parkinson\u2019s disease. Move Disord 29:904\u2013911","journal-title":"Move Disord"},{"key":"2771_CR110","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neubiorev.2013.11.001","volume":"38","author":"C Vriend","year":"2014","unstructured":"Vriend C, Pattij T, van der Werf YD, Voorn P, Booij J, Rutten S, Berendse HW, van den Heuvel OA (2014b) Depression and impulse control disorders in Parkinson\u2019s disease: two sides of the same coin? Neurosci Biobehav Rev 38:60\u201371","journal-title":"Neurosci Biobehav Rev"},{"key":"2771_CR111","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/jnnp-2012-304811","volume":"85","author":"C Vriend","year":"2014","unstructured":"Vriend C, Raijmakers P, Veltman DJ, van Dijk KD, van der Werf YD, Foncke EM, Smit JH, Berendse HW, van den Heuvel OA (2014c) Depressive symptoms in Parkinson\u2019s disease are related to reduced [123I]FP-CIT binding in the caudate nucleus. J Neurol Neurosurg Psychiatry 85:159\u2013164","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2771_CR112","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.neurobiolaging.2014.07.031","volume":"36","author":"C Vriend","year":"2015","unstructured":"Vriend C, Gerrits NJ, Berendse HW, Veltman DJ, van den Heuvel OA, van der Werf YD (2015) Failure of stop and go in de novo Parkinson\u2019s disease--a functional magnetic resonance imaging study. Neurobiol Aging 36:470\u2013475","journal-title":"Neurobiol Aging"},{"key":"2771_CR113","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1001\/archneurol.2010.65","volume":"67","author":"D Weintraub","year":"2010","unstructured":"Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, Whetteckey J, Wunderlich GR, Lang AE (2010) Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 67:589\u2013595","journal-title":"Arch Neurol"},{"key":"2771_CR114","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1212\/WNL.0b013e31827b915c","volume":"80","author":"D Weintraub","year":"2013","unstructured":"Weintraub D, Papay K, Siderowf A, Parkinson\u2019s Progression Markers I (2013) Screening for impulse control symptoms in patients with de novo Parkinson disease: a case-control study. Neurology 80:176\u2013180","journal-title":"Neurology"},{"key":"2771_CR115","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/mds.26016","volume":"30","author":"D Weintraub","year":"2015","unstructured":"Weintraub D, David AS, Evans AH, Grant JE, Stacy M (2015) Clinical spectrum of impulse control disorders in Parkinson\u2019s disease. Move Disord 30:121\u2013127","journal-title":"Move Disord"},{"key":"2771_CR116","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1038\/sj.npp.1300434","volume":"29","author":"CA Winstanley","year":"2004","unstructured":"Winstanley CA, Dalley JW, Theobald DE, Robbins TW (2004) Fractionating impulsivity: contrasting effects of central 5-HT depletion on different measures of impulsive behavior. Neuropsychopharmacology 29:1331\u20131343","journal-title":"Neuropsychopharmacology"},{"key":"2771_CR117","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.parkreldis.2014.01.019","volume":"20","author":"K Wu","year":"2014","unstructured":"Wu K, Politis M, O\u2019Sullivan SS, Lawrence AD, Warsi S, Lees A, Piccini P (2014) Problematic internet use in Parkinson\u2019s disease. Parkinsonism Relat Disord 20:482\u2013487","journal-title":"Parkinsonism Relat Disord"},{"key":"2771_CR118","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1007\/s00415-015-7722-7","volume":"262","author":"K Wu","year":"2015","unstructured":"Wu K, Politis M, O\u2019Sullivan SS, Lawrence AD, Warsi S, Bose S, Lees AJ, Piccini P (2015) Single versus multiple impulse control disorders in Parkinson\u2019s disease: an (1)(1)C-raclopride positron emission tomography study of reward cue-evoked striatal dopamine release. J Neurol 262:1504\u20131514","journal-title":"J Neurol"},{"key":"2771_CR119","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1093\/brain\/awu032","volume":"137","author":"Z Ye","year":"2014","unstructured":"Ye Z, Altena E, Nombela C, Housden CR, Maxwell H, Rittman T, Huddleston C, Rae CL, Regenthal R, Sahakian BJ, Barker RA, Robbins TW, Rowe JB (2014) Selective serotonin reuptake inhibition modulates response inhibition in Parkinson\u2019s disease. Brain J Neurol 137:1145\u20131155","journal-title":"Brain J Neurol"},{"key":"2771_CR120","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.biopsych.2014.01.024","volume":"77","author":"Z Ye","year":"2015","unstructured":"Ye Z, Altena E, Nombela C, Housden CR, Maxwell H, Rittman T, Huddleston C, Rae CL, Regenthal R, Sahakian BJ, Barker RA, Robbins TW, Rowe JB (2015) Improving response inhibition in Parkinson\u2019s disease with atomoxetine. Biol Psychiatry 77:740\u2013748","journal-title":"Biol Psychiatry"},{"key":"2771_CR121","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12883-015-0316-2","volume":"15","author":"S Zainal Abidin","year":"2015","unstructured":"Zainal Abidin S, Tan EL, Chan SC, Jaafar A, Lee AX, Abd Hamid MH, Abdul Murad NA, Pakarul Razy NF, Azmin S, Ahmad Annuar A, Lim SY, Cheah PS, Ling KH, Mohamed Ibrahim N (2015) DRD and GRIN2B polymorphisms and their association with the development of impulse control behaviour among Malaysian Parkinson\u2019s disease patients. BMC Neurol 15:59","journal-title":"BMC Neurol"}],"container-title":["Cell and Tissue Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00441-017-2771-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00441-017-2771-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00441-017-2771-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T19:11:07Z","timestamp":1548789067000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00441-017-2771-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,30]]},"references-count":121,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["2771"],"URL":"https:\/\/doi.org\/10.1007\/s00441-017-2771-0","relation":{},"ISSN":["0302-766X","1432-0878"],"issn-type":[{"value":"0302-766X","type":"print"},{"value":"1432-0878","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,30]]},"assertion":[{"value":"9 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author declares no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}